VIP-ergic and cholinergic innervations in internal carotid arteries of the cat and rat.
Miao. F J FJ; Lee. T J TJ
Key Findings
- Both cholinergic (ACh) and VIP-ergic nerves are present in cerebral arteries, with varicosity‑like structures suggesting true nerve endings.
- ACh causes low‑dose vasodilation (via endothelial nitric oxide and cGMP) and high‑dose vasoconstriction (via phosphatidyl‑inositol turnover).
- VIP induces endothelium‑independent vasodilation mediated by cAMP, which is blocked by the VIP receptor antagonist GRF‑1‑29.
Practical Outcomes
- For biohackers, the work mainly confirms that VIP signaling can affect brain blood flow, but it does not provide a clear, safe way to use GRF‑1‑29 or related peptides in humans. No direct dosing or protocol guidance emerges, so the study has limited immediate applicability for longevity or performance optimization.
Summary
The study shows that cat and rat brain arteries are wired with nerves that release acetylcholine (ACh) and VIP, which can make the vessels widen or tighten depending on the dose. VIP makes the arteries relax even without the inner lining, and a synthetic peptide called GRF‑1‑29 blocks this effect. The findings are mostly basic science about how blood vessels are controlled in animals.
Abstract
Using immunohistochemical methods, choline acetyltransferase and vasoactive intestinal polypeptide immunoreactive (ChAT-I and VIP-I) fine fibers with varicosity-like structures were observed in the rat and cat cerebral arteries. Acetylcholine (ACh) induced dual responses in endothelium-intact internal carotid arteries of the cat; it induced vasodilation at low concentrations and constrictions at high concentrations (greater than 10(-6) M). ACh induced contraction exclusively in endothelium-rubbed preparations. Atropine (10(-7) M) blocked ACh-induced constriction and dilatation. ACh-induced vasodilation was potentiated by M & B 22,948 (2 x 10(-5) M), a selective cyclic GMP phosphodiesterase inhibitor. Vasoconstriction induced by ACh was inhibited by neomycin (3 x 10(-3) M), an inositol phosphate synthesis inhibitor, which did not affect the neuropeptide Y-induced contraction. VIP-induced dilation of the cat internal carotid arteries was not affected by removing the endothelial layer, but was blocked by VIP receptor antagonist ([Ac-Tyr1, D-Phe2]-GRF 1-29 amide) and potentiated by cilostazol (2 x 10(-5) M), a selective cyclic AMP phosphodiesterase inhibitor. These results are consistent with previous findings that cerebral blood vessels receive cholinergic and VIP-ergic innervations, and that ACh-induced endothelium-dependent vasodilation is mediated by cyclic GMP synthesis, and that VIP-induced endothelium-independent vasodilation is mediated by cyclic AMP synthesis. The present study, however, demonstrates for the first time the presence of varicosity-like structure associated with ChAT-I fibers, suggesting the presence of cholinergic nerve terminals and that ACh-induced cerebral vasoconstriction is mediated by phosphatidyl-inositide turnover.
Study Information
pubmed
1991
1991-09-01T00:00:00.000Z
10.1097/00005344-199109000-00010
19